9 Amendments of Biljana BORZAN related to 2014/2207(INI)
Amendment 12 #
Motion for a resolution
Recital D
Recital D
D. whereas a multidisciplinary approach guarantees appropriateincreases the chances of positive outcomes of medical treatments;
Amendment 25 #
Motion for a resolution
Recital G
Recital G
G. whereas continuous training of doctorhealthcare professionals is crucial to avoid adverse events, including adverse drug events (ADEs), which are estimated to cost the EU healthcare systems some EUR 2.7 billion per year in care expenses and account for 1.1 % of all hospitalisations in the EU;
Amendment 105 #
Motion for a resolution
Paragraph 1 a (new)
Paragraph 1 a (new)
1a. Recalls that the EU pharmaceutical legislation was put in place to protect patient safety and recalls the European Parliament's resolution of October 22 2013 on the report from the Commission to the Council on the basis of Member States' reports on the implementation on the Council Recommendation (2009/C 151/01) on patient safety, including the prevention and control of healthcare- associated infections (2013/2022(INI));
Amendment 121 #
Motion for a resolution
Paragraph 6 – point a
Paragraph 6 – point a
a) continue their efforts to improve patient safety by taking, if they have not already done so, new the necessary measures in order to fully implement the Council’s recommendations;
Amendment 126 #
Motion for a resolution
Paragraph 6 – point c
Paragraph 6 – point c
c) ensure appropriate training of doctors and other healthcare professionals and set up monitoring systems to verify that their competences are up-to-date with hospital hygiene practices and the technology in place;
Amendment 139 #
Motion for a resolution
Paragraph 6 – point e a (new)
Paragraph 6 – point e a (new)
ea) Calls on Member States to investigate possible malpractice involved in the refurbishment and re-use of medical devices originally designed and labelled for single use;
Amendment 175 #
Motion for a resolution
Paragraph 12 a (new)
Paragraph 12 a (new)
12a. Calls on Member States to inform patients about the risks and preventive measures relating to adverse events in healthcare, and about the complaints procedures and legal options available should an adverse event occur via e.g. a patient rights representative;
Amendment 242 #
Motion for a resolution
Paragraph 22 – point b
Paragraph 22 – point b
b) regulate the sale and distribution of antibiotics so that patients can buy only obtain the specific quantity of antibiotics as prescribed by their doctors;
Amendment 248 #
Motion for a resolution
Paragraph 22 – point c
Paragraph 22 – point c
c) ensuredevelop strategies to support patients’' adherence to and compliance with antibiotic and other appropriate treatments as prescribed by medical professionals;